Press release
Non-Viral Drug Delivery Systems Market is expected to surpass USD 110.7 billion by 2034
Non-Viral Drug Delivery Systems
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73463
These systems include lipid nanoparticles (LNPs), polymer-based carriers, dendrimers, micelles, and inorganic nanoparticles. They are central to mRNA vaccines, gene therapies, oncology treatments, and chronic disease management. With the rise of personalized medicine, biologics, and RNA-based therapeutics, the demand for non-viral systems is growing rapidly.
Market Overview
• Market Size (2024): USD 52.3 billion
• Forecast (2034): USD 110.7 billion
• CAGR (2025-2034): 7.8%
Key Highlights:
• Non-viral delivery systems dominate RNA-based vaccine development.
• Growing adoption in oncology and rare-disease therapies.
• Safer alternatives to viral vectors, with scalable manufacturing.
• Heavy investment from pharma, biotech, and nanomedicine startups.
Segmentation Analysis
By Delivery System Type:
• Lipid-Based Systems (LNPs, liposomes)
• Polymer-Based Systems (PLGA, dendrimers, hydrogels)
• Inorganic Nanoparticles (gold nanoparticles, silica)
• Micelles & Emulsions
• Others (hybrid systems)
By Technology:
• Nanoparticle-Based Delivery
• Physical Methods (electroporation, ultrasound-mediated delivery)
• Chemical-Based Delivery (cationic polymers, pH-sensitive carriers)
By Application:
• Oncology (chemotherapy, immunotherapy delivery)
• Infectious Diseases (vaccines, antivirals)
• Genetic Disorders (gene silencing, mRNA therapies)
• Autoimmune & Chronic Diseases
• Others (neurology, ophthalmology)
By End Use:
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Hospitals & Specialty Clinics
• Contract Research & Manufacturing Organizations (CROs/CMOs)
Segmentation Summary:
Lipid nanoparticles (LNPs) lead the market, fueled by their success in COVID-19 mRNA vaccines and their use in ongoing RNA therapeutics. Polymer-based systems are expected to grow rapidly, offering versatility and biodegradability.
Explore Full Report here: https://exactitudeconsultancy.com/reports/73463/non-viral-drug-delivery-systems-market
Regional Analysis
North America
• Largest market (~45% share in 2024).
• Strong biotech ecosystem and mRNA therapeutic pipeline.
• FDA approvals of LNP-based vaccines boost adoption.
Europe
• ~30% share.
• EU investment in nanomedicine research.
• Germany, UK, and France leading in RNA vaccine and gene therapy research.
Asia-Pacific
• Fastest-growing region with CAGR of ~9.2%.
• Expanding biotech hubs in China, Japan, South Korea, and India.
• Increasing investments in local nanomedicine startups.
Middle East & Africa
• Emerging adoption for vaccine programs.
• Limited high-end research infrastructure but expanding collaborations.
Latin America
• Brazil and Mexico driving growth through vaccine adoption and clinical trials.
Regional Summary:
North America and Europe lead adoption today, while Asia-Pacific is the fastest-growing hub for nanomedicine and gene delivery, supported by expanding biotech ecosystems and government funding.
Market Dynamics
Key Growth Drivers:
• Expanding pipeline of RNA-based vaccines and therapies.
• Growing demand for oncology drug delivery systems.
• Advantages over viral vectors (lower immunogenicity, scalability).
• Expansion of nanomedicine R&D and manufacturing.
Key Challenges:
• Stability and delivery efficiency in complex biological environments.
• Manufacturing scale-up challenges.
• Regulatory uncertainties around newer nanocarriers.
• Cost and complexity of next-gen formulations.
Latest Trends:
• Growth of LNPs in RNA vaccine delivery beyond COVID-19.
• Development of hybrid carriers (lipid-polymer conjugates).
• Advances in stimuli-responsive carriers (pH, heat, light sensitive).
• Integration of AI in drug delivery system design.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73463
Competitor Analysis
Major Players in the Market:
• Moderna, Inc. (LNP-based mRNA vaccines and therapeutics)
• BioNTech SE
• Pfizer, Inc.
• Arbutus Biopharma Corp.
• CureVac N.V.
• Johnson & Johnson
• AstraZeneca plc
• Novartis AG
• Precision NanoSystems (PNI - lipid nanoparticle tech)
• Evonik Industries AG (nanoparticle manufacturing)
Competitive Summary:
Moderna, BioNTech, and Pfizer dominate RNA delivery via LNPs. Arbutus and CureVac drive innovation in lipid/polymer platforms. Precision NanoSystems and Evonik focus on enabling technologies. Competition is defined by delivery efficiency, stability, and therapeutic versatility.
Conclusion
The Non-Viral Drug Delivery Systems Market, valued at USD 52.3 billion in 2024, is projected to reach USD 110.7 billion by 2034, expanding at a CAGR of 7.8%.
Key Takeaways:
• Lipid nanoparticles dominate, polymer systems are fast-growing.
• Oncology and infectious disease applications lead adoption.
• North America and Europe dominate today, APAC grows fastest.
• Future growth will hinge on RNA-based therapies, hybrid systems, and scalable nanomedicine manufacturing.
Over the next decade, non-viral drug delivery will be central to precision medicine, RNA therapeutics, and next-gen biologics, creating major opportunities for pharma, biotech, and materials innovators.
This report is also available in the following languages : Japanese (非ウイルス性薬物送達システム市場), Korean (비바이러스 약물 전달 시스템 시장), Chinese (非病毒药物输送系统市场), French (Marché des systèmes d'administration de médicaments non viraux), German (Markt für nicht-virale Arzneimittelabgabesysteme), and Italian (Mercato dei sistemi di somministrazione di farmaci non virali), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/73463/non-viral-drug-delivery-systems-market#request-a-sample
Our More Reports:
Cell Therapy Media Market
https://exactitudeconsultancy.com/reports/73529/cell-therapy-media-market
Cell Therapy Packaging Market
https://exactitudeconsultancy.com/reports/73531/cell-therapy-packaging-market
Cold Chain Logistics Market
https://exactitudeconsultancy.com/reports/73533/cold-chain-logistics-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-Viral Drug Delivery Systems Market is expected to surpass USD 110.7 billion by 2034 here
News-ID: 4182498 • Views: …
More Releases from Exactitude Consultancy
Portable X-Ray Devices Market is expected to reach USD 15.4 billion by 2034
Portable X-ray devices have transformed diagnostic imaging by enabling bedside, field, and remote healthcare imaging without the need for patients to visit traditional radiology departments. These devices are widely used in emergency care, ICUs, military medicine, home healthcare, and rural health programs.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73465
The market is witnessing strong growth due to the rising demand for point-of-care diagnostics, advancements in digital imaging, growing adoption…
Point-of-Care Diagnostics Market is expected to reach USD 78.5 billion by 2034
Point-of-care (POC) diagnostics refers to medical testing performed at or near the patient's location rather than in centralized laboratories. These tests deliver rapid, reliable results that aid clinical decision-making in real time. From blood glucose meters and pregnancy kits to COVID-19 antigen tests, cardiac markers, and infectious disease assays, POC diagnostics has become a critical part of global healthcare delivery.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73467
The market…
Diabetes Drug Delivery Devices Market to Reach $35.4 Billion by 2034
Diabetes remains one of the most pressing global health challenges, affecting more than 500 million people worldwide and projected to rise sharply by 2030. Effective management relies heavily on timely and accurate drug delivery systems, which ensure proper dosing and patient adherence.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73469
The diabetes drug delivery devices market has evolved from conventional syringes to advanced technologies such as smart insulin pens, wearable…
Non-Invasive Neurostimulation Devices Market to Reach USD 7.1 Billion by 2034
Non-invasive neurostimulation devices use electrical or magnetic impulses to modulate neural activity without requiring surgery. They are applied in chronic pain management, depression, epilepsy, migraine, movement disorders, and rehabilitation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73471
With the rising burden of neurological disorders, growing demand for non-pharmacological treatments, and breakthroughs in wearable brain-health technologies, the market is entering a new growth phase.
Market Overview
• Market Size (2024): USD 3.4 billion
• Forecast (2034):…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
